Star Exports Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Star Exports Pharmaceutical Export Portfolio Dataset — 3 Products, $1.3M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Star Exports — Pharmaceutical Exporter Profile (2026) | 3 Products, $1.3M Trade | TransData Nexus

Star Exports

Indian Pharmaceutical Exporter · Brand Names & OTC Products Specialist · $1.3M Total Trade · DGFT Verified

Star Exports is an Indian pharmaceutical exporter with a total trade value of $1.3M across 3 products in 1 therapeutic categories. Based on 147 verified export shipments from Indian Customs (DGFT) records, Star Exports is the #1 Indian exporter in 2 products including Dettol, Burnol. Top exports include Dettol ($1.3M), Iodex ($32.5K), Burnol ($19.5K).

Star Exports — Export Portfolio & Destination Treemap

Star Exports pharmaceutical export portfolio — 3 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Star Exports? — Company Overview & Market Position

Star Exports is a globally recognized trading and wholesale company based in Mumbai, India, with over 32 years of experience in the export industry. Established in 1990, the company specializes in exporting finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, as well as toiletries, cosmetics, and fast-moving consumer goods (FMCG). Their portfolio features renowned Indian brands such as Dettol, Iodex, and Burnol.

The company operates under the ownership of Mr. Samir Rokadia, who serves as the Proprietor. Star Exports is registered with the Directorate General of Foreign Trade (DGFT), reflecting its compliance with Indian export regulations. While specific financial details are not publicly disclosed, the company has achieved a total export value of $1.3 million USD over 147 shipments from 2022 to 2026. The workforce comprises approximately 11 to 50 employees, indicating a medium-sized enterprise.

What Does Star Exports Export? — Product Portfolio Analysis

Top Products by Export Value

1Dettol$1.3M 2

Product Portfolio — Top 3 by Export Value

Star Exports exports 3 pharmaceutical products across 1 therapeutic categories. Market leader (#1 exporter) in 2 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Dettol	Brand Names & OTC Products	$1.3M	117	14.7%	1
2	Iodex	Brand Names & OTC Products	$32.5K	20	0.5%	8
3	Burnol	Brand Names & OTC Products	$19.5K	10	30.0%	1

Star Exports exports 3 pharmaceutical products across 1 therapeutic categories with a total export value of $1.3M. The company is the #1 Indian exporter in 2 products: Dettol, Burnol. The top category is Brand Names & OTC Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Star Exports — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Star Exports operates manufacturing facilities in Mumbai, Maharashtra, India. The company specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding plant capacities and specialized manufacturing processes are not publicly disclosed. However, the company's extensive experience and export volume suggest a well-established manufacturing infrastructure capable of meeting international standards.

3Key Leadership

The leadership of Star Exports is headed by Mr. Samir Rokadia, who serves as the Proprietor. Specific details regarding other key executives, such as the CEO, CFO, and other senior management roles, are not publicly available. The company's leadership is known for its commitment to quality and customer satisfaction, as evidenced by their adherence to ethical practices and social responsibility.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Star Exports Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Star Exports has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company exports finished pharmaceutical formulations, such as Dettol, Iodex, and Burnol, which are recognized and approved in these regions. While specific regulatory filings and approvals are not publicly disclosed, the company's adherence to international quality standards and ethical practices suggests compliance with the regulatory requirements of these markets.

2Emerging Markets

Star Exports has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's products, including Dettol, Iodex, and Burnol, are recognized and approved in these regions. While specific details regarding WHO prequalification are not publicly available, the company's commitment to quality and ethical practices indicates a focus on meeting international standards to facilitate market access.

3Geographic Strategy

Star Exports demonstrates a diversified geographic strategy by exporting to both regulated markets and emerging economies. This approach mitigates concentration risk and positions the company to leverage growth opportunities across different regions. The strategic direction appears to focus on expanding market reach while maintaining a strong presence in established markets.

Star Exports — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Star Exports' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's export of recognized pharmaceutical products such as Dettol, Iodex, and Burnol suggests compliance with FDA regulations. The company's adherence to international quality standards and ethical practices further indicates a commitment to meeting regulatory requirements.

2WHO & EU GMP

While specific details regarding WHO prequalification and EU Good Manufacturing Practice (GMP) certificates are not publicly available, Star Exports' export of recognized pharmaceutical products such as Dettol, Iodex, and Burnol suggests adherence to international quality standards. The company's commitment to ethical practices and social responsibility further indicates a focus on meeting global manufacturing standards.

3CDSCO & Indian Regulatory

Star Exports operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company holds manufacturing licenses and approvals from state drug controllers, ensuring compliance with Indian pharmaceutical regulations. Specific details regarding export No Objection Certificates (NOCs) are not publicly available. However, the company's adherence to ethical practices and social responsibility suggests a commitment to meeting regulatory requirements for international trade.

Star Exports — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the pharmaceutical export sector, Star Exports faces competition from other Indian exporters specializing in finished pharmaceutical formulations. While specific market share data is not publicly available, the company's export value of $1.3 million USD over 147 shipments from 2022 to 2026 indicates a significant presence in the market. The company's focus on recognized brands such as Dettol, Iodex, and Burnol positions it favorably against competitors.

2Key Differentiators

Star Exports' key differentiators include its extensive experience of over 32 years in the export industry, a diversified product portfolio featuring renowned Indian brands, and a commitment to quality and ethical practices. The company's adherence to international standards and social responsibility further distinguishes it in the competitive landscape.

3Strategic Position

Star Exports' current strategic direction focuses on exporting finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, as well as FMCG products. The company's future outlook appears to involve expanding its market reach while maintaining a strong presence in established markets. The commitment to quality and ethical practices suggests a focus on sustainable growth and long-term success.

Buyer Due Diligence Brief — Evaluating Star Exports as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Star Exports has a track record of exporting recognized pharmaceutical products such as Dettol, Iodex, and Burnol, indicating reliability and consistency in its export operations. The company's export value of $1.3 million USD over 147 shipments from 2022 to 2026 reflects a steady volume of trade. The commitment to quality and ethical practices further enhances its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications when considering Star Exports as a supplier:

FDA Facility Registration: Confirm the registration status of Star Exports' manufacturing facilities with the U.S. Food and Drug Administration (FDA).

WHO-GMP Certification: Verify the World Health Organization's Good Manufacturing Practice (GMP) certification for the company's manufacturing facilities.

EU GMP Certification: Ensure the company holds Good Manufacturing Practice certification recognized by the European Union.

Frequently Asked Questions — Star Exports

How many pharmaceutical products does Star Exports export from India?

Star Exports exports 3 pharmaceutical products across 1 therapeutic categories. The top exports are Dettol ($1.3M), Iodex ($32.5K), Burnol ($19.5K). Total export value is $1.3M.

What is Star Exports's total pharmaceutical export value?

Star Exports's total pharmaceutical export value is $1.3M, based on 147 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Star Exports the #1 Indian exporter?

Star Exports is the #1 Indian exporter in 2 products: Dettol (14.7% market share), Burnol (30.0% market share).

What therapeutic categories does Star Exports cover?

Star Exports exports across 1 therapeutic categories. The largest are Brand Names & OTC Products (100.0%, 3 products).

Get Full Star Exports Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.